Chemed (CHE) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Chemed

NYSE•Healthcare•Medical Care Facilities

$533.65-8.53(-0.02%)Pre-market

Market Cap

$6.97B

P/E

24.7x

P/S

2.6x

P/B

8.1x

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

How this company scores

GoodMetricSide Score: 71/100

Strongest: Balance Sheet & Red Flags (20/25); weakest: Cash & Earnings Quality (16/25).

Profitability18/25

Growth17/25

Balance Sheet & Red Flags20/25

Cash & Earnings Quality16/25

Strengths

High ROELow leverageInterest easily coveredCash-backed earnings

No red flags in the last 8 quarters.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 24.7x5y range 19.7x – 34.9x

Currently near its 20-quarter median.

P/S · 2.6x5y range 2.0x – 3.7x

Currently near its 20-quarter median.

P/B · 8.1x5y range 5.9x – 12.9x

Price & Volume

Market Cap $6.97B

Metrics at a Glance

as of September 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $2.66B
Q. Revenue: $690.94M
TTM EBITDA: $438.45M
TTM Op. Income: $370.86M
Q. Op. Income: $96.42M
TTM Net Income: $282.40M
Q. Net Income: $71.65M
EPS: $5.49
Shares Out.: $13.06M

$2.66B in TTM revenue grew 5.2% YoY, reaching $690.94M last quarter. TTM EBITDA of $438.45M and TTM operating income of $370.86M show growth is flowing through to the bottom line. TTM net income of $282.40M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 3 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 33.7%
EBITDA Margin: 16.5%
Op. Margin: 14.0%
Net Margin: 10.4%

Op. margin of 14.0% is up 2.0% YoY — cost efficiency is improving. Net margin at 10.4% and gross margin of 33.7% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 24.7x
P/S Ratio: 2.6x
P/B Ratio: 8.1x

At 24.7x P/E, the stock trades within typical market levels. P/S of 2.6x and P/B of 8.1x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has risen for 2 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $1.72B
Cash: $48.43M
Long-Term Debt: $236.00M
Book Value: $861.42M
D/E Ratio: 0.3
Debt/EBITDA: 2.1

With $1.72B in assets and $236.00M in long-term debt, D/E is 0.3and book value is $861.42M — a conservative capital structure with a cushion to weather downturns. Across the last 3 quarters, debt/equity has risen for 2 consecutive quarters — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $56.59M
TTM Free Cash Flow: $295.45M
FCF Margin: 11.1%
FCF / Net Income: 1.0

TTM FCF of $295.45M on $56.59M in operating cash flow. The FCF / Net Income ratio of 1.0x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has fallen for 2 consecutive quarters — a weakening trend.